Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Hox proteins help maintain keratinocyte identity by regulating miRNA expression.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Immune activities and specific genes are important in male pattern baldness.

NFIB and STAT5 work together to control specific genetic programs in cells.

CD2 might be a new treatment target for patchy alopecia areata.

Retinol may affect immune responses in people with frequent skin boils.

Obesity may weaken the immune system and increase cancer risk.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Common gene patterns may cause skin autoimmune diseases.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Transplant success has improved with better immunosuppressive drugs and donor matching.

ceRNA networks offer potential treatments for skin aging and wound healing.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

IL-27 may help prevent hair loss by creating immune-suppressing cells.